FDA Approved: PROGLYCEM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental NDA for PROGLYCEM (diazoxide) from Teva Pharmaceuticals USA, expanding or updating its labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Hyperinsulinism
• Hypoglycemia

Drugs mentioned

• PROGLYCEM (Diazoxide)

Snippet

SUPPL AP for PROGLYCEM (DIAZOXIDE)